Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin

Clinical Infectious Diseases

Volumn 24, Issue 6, 1997, Pages 1264-1265

  Ridzon, Renée ^a   Meador, Jody ^b   Maxwell, Roberta ^b   Higgins, Kathy ^b   Weismuller, Penny ^b   Onorato, Ida M ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; DISEASE TRANSMISSION; DRUG EFFICACY; FEMALE; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION PREVENTION; LUNG TUBERCULOSIS; MALE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030926755     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.6.1264     Document Type: Article

References (5)

1. Centers for Disease Control and Prevention. Management of persons exposed to multi-drug resistant tuberculosis. MMWR 1992;41(RR-11): 61-71.
2. Villarino ME, Simone PM, McCray E, Bloch AB, Castro KG. Preventive therapy for multidrug-resistant tuberculosis [letter]. JAMA 1996;276: 27-8.
3. Scharer L, Smith J. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann Intern Med 1969;71: 1113-20.
4. American Thoracic Society. Preventive treatment of tuberculosis. Am Rev Respir Dis 1971;104:460-3.
5. Horn DE, Hewlett D, Alfalla C, Peterson S. Eimited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis [letter]. N Engl J Med 1994;330:1241.